anti-IGF1R recombinant monoclonal antibody MK-0646
Term · Oncology and biomedicine · MLC-T-ONC-000623
A substance being studied in the treatment of many types of cancer. Anti-IGF1R recombinant monoclonal antibody MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. Anti-IGF1R recombinant monoclonal antibody MK-0646 is a type of monoclonal antibody. Also called MK-0646.
| Identifier | MLC-T-ONC-000623 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MK-0646 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000623",
"term": "anti-IGF1R recombinant monoclonal antibody MK-0646",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of many types of cancer. Anti-IGF1R recombinant monoclonal antibody MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. Anti-IGF1R recombinant monoclonal antibody MK-0646 is a type of monoclonal antibody. Also called MK-0646.",
"synonyms": [
"MK-0646"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/anti-igf1r-recombinant-monoclonal-antibody-mk-0646/"
}
Record 1,920 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.